Post-conditioning by xenon reduces ischaemia-reperfusion injury of the spinal cord in rats

Acta Anaesthesiologica Scandinavica

Volumn 56, Issue 10, 2012, Pages 1325-1331

  Yang, Y W ^a   Lu, J K ^a   Qing, E M ^a   Dong, X H ^a   Wang, C B ^a   Zhang, J ^a   Zhao, L Y ^a   Gao, Z F ^a   Cheng, W P ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

NITROGEN; XENON;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BALLOON OCCLUSION; BLOOD BRAIN BARRIER; CELL DEATH; CONTROLLED STUDY; HISTOPATHOLOGY; ISCHEMIC POSTCONDITIONING; MALE; NERVE CELL; NEUROPROTECTION; NICK END LABELING; NISSL STAINING; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; SCORING SYSTEM; SHAM PROCEDURE; SPINAL CORD INJURY; SPINAL CORD ISCHEMIA; SURGICAL TECHNIQUE; THORACIC AORTA; TRANSMISSION ELECTRON MICROSCOPY;

ADMINISTRATION, INHALATION; ANESTHETICS, INHALATION; ANIMALS; APOPTOSIS; HINDLIMB; IN SITU NICK-END LABELING; LOCOMOTION; MALE; MICROSCOPY, ELECTRON, TRANSMISSION; NEURONS; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; SPINAL CORD; SPINAL CORD ISCHEMIA; XENON;

EID: 84867583183     PISSN: 00015172     EISSN: 13996576     Source Type: Journal    
DOI: 10.1111/j.1399-6576.2012.02718.x     Document Type: Article

References (37)

1. Kuniyoshi Y, Koja K, Miyagi K, Shimoji M, Uezu T, Arakaki K, Yamashiro S, Mabuni K, Senaha S, Nakasone Y,. Prevention of postoperative paraplegia during thoracoabdominal aortic surgery. Ann Thorac Surg 2003; 76: 1477-1484.
2. Cox GS, O'Hara PJ, Hertzer NR, Piedmonte MR, Krajewski LP, Beven EG,. Thoracoabdominal aneurysm repair: a representative experience. J Vasc Surg 1992; 15: 780-787.
3. Svensson LG, Crawford ES, Hess KR, Coselli JS, Safi HJ,. Experience with 1509 patients undergoing thoracoabdominal aortic operations. J Vasc Surg 1993; 17: 357-368.
4. Griepp RB, Ergin MA, Galla JD, Lansman S, Khan N, Quintana C, McCollough J, Bodian C,. Looking for the artery of adamkiewicz: a quest to minimize paraplegia after operations for aneurysms of the descending thoracic and thoracoabdominal aorta. J Thorac Cardiovasc Surg 1996; 112: 1202-1213.
5. Safi HJ, Miller CC, 3rd, Carr C, Iliopoulos DC, Dorsay DA, Baldwin JC,. Importance of intercostal artery reattachment during thoracoabdominal aortic aneurysm repair. J Vasc Surg 1998; 27: 58-66.
6. Cambria RP, Davison JK, Carter C, Brewster DC, Chang Y, Clark KA, Atamian S,. Epidural cooling for spinal cord protection during thoracoabdominal aneurysm repair: a five-year experience. J Vasc Surg 2000; 31: 1093-1102.
7. Cambria RP, Clouse WD, Davison JK, Dunn PF, Corey M, Dorer D,. Thoracoabdominal aneurysm repair: results with 337 operations performed over a 15-year interval. Ann Surg 2002; 236: 471-479.
8. Maniar HS, Sundt TM, 3rd, Prasad SM, Chu CM, Camillo CJ, Moon MR, Rubin BG, Sicard GA,. Delayed paraplegia after thoracic and thoracoabdominal aneurysm repair: a continuing risk. Ann Thorac Surg 2003; 75: 113-119.
9. Chiesa R, Melissano G, Civilini E, de, Moura ML, Carozzo A, Zangrillo A,. Ten years experience of thoracic and thoracoabdominal aortic aneurysm surgical repair: lessons learned. Ann Vasc Surg 2004; 18: 514-520.
10. MacArthur RG, Carter SA, Coselli JS, LeMaire SA,. Organ protection during thoracoabdominal aortic surgery: rationale for a multimodality approach. Semin Cardiothorac Vasc Anesth 2005; 9: 143-149.
11. Wan IY, Angelini GD, Bryan AJ, Ryder I, Underwood MJ,. Prevention of spinal cord ischaemia during descending thoracic and thoracoabdominal aortic surgery. Eur J Cardiothorac Surg 2001; 19: 203-213.
12. Luttropp HH, Thomasson R, Dahm S, Persson J, Werner O,. Clinical experience with minimal flow xenon anesthesia. Acta Anaesthesiol Scand 1994; 38: 121-125.
13. Nakata Y, Goto T, Morita S,. Comparison of inhalation inductions with xenon and sevoflurane. Acta Anaesthesiol Scand 1997; 41: 1157-1161.
14. Derwall M, Coburn M, Rex S, Hein M, Rossaint R, Fries M,. Xenon: recent developments and future perspectives. Minerva Anestesiol 2009; 75: 37-45.
15. Hobbs C, Thoresen M, Tucker A, Aquilina K, Chakkarapani E, Dingley J,. Xenon and hypothermia combine additively, offering long-term functional and histopathologic neuroprotection after neonatal hypoxia/ischemia. Stroke 2008; 39: 1307-1313.
16. David HN, Leveille F, Chazalviel L, MacKenzie ET, Buisson A, Lemaire M, Abraini JH,. Reduction of ischemic brain damage by nitrous oxide and xenon. J Cereb Blood Flow Metab 2003; 23: 1168-1173.
17. Petzelt C, Blom P, Schmehl W, Muller J, Kox WJ,. Prevention of neurotoxicity in hypoxic cortical neurons by the noble gas xenon. TIT J Life Sci 2003; 72: 1909-1918.
18. Wilhelm S, Ma D, Maze M, Franks NP,. Effects of xenon on in vitro and in vivo models of neuronal injury. Anesthesiology 2002; 96: 1485-1491.
19. Homi HM, Yokoo N, Ma D, Warner DS, Franks NP, Maze M, Grocott HP,. The neuroprotective effect of xenon administration during transient middle cerebral artery occlusion in mice. Anesthesiology 2003; 99: 876-881.
20. Chen M, Lu TJ, Chen XJ, Zhou Y, Chen Q, Feng XY, Xu L, Duan WH, Xiong ZQ,. Differential roles of nmda receptor subtypes in ischemic neuronal cell death and ischemic tolerance. Stroke 2008; 39: 3042-3048.
21. David HN, Haelewyn B, Rouillon C, Lecoq M, Chazalviel L, Apiou G, Risso JJ, Lemaire M, Abraini JH,. Neuroprotective effects of xenon: a therapeutic window of opportunity in rats subjected to transient cerebral ischemia. FASEB J 2008; 22: 1275-1286.
22. Jiang X, Ai C, Shi E, Nakajima Y, Ma H,. Neuroprotection against spinal cord ischemia-reperfusion injury induced by different ischemic postconditioning methods: roles of phosphatidylinositol 3-kinase-akt and extracellular signal-regulated kinase. Anesthesiology 2009; 111: 1197-1205.
23. Jiang X, Shi E, Nakajima Y, Sato S,. Postconditioning, a series of brief interruptions of early reperfusion, prevents neurologic injury after spinal cord ischemia. Ann Surg 2006; 244: 148-153.
24. Yamamoto Y, Kawaguchi M, Kurita N, Kakimoto M, Inoue S, Furuya H,. Effects of xenon on ischemic spinal cord injury in rabbits: a comparison with propofol. Acta Anaesthesiol Scand 2010; 54: 337-342.
25. Sinha AC, Cheung AT,. Spinal cord protection and thoracic aortic surgery. Curr Opin Anaesthesiol 2010; 23: 95-102.
26. Preckel B, Weber NC, Sanders RD, Maze M, Schlack W,. Molecular mechanisms transducing the anesthetic, analgesic, and organ-protective actions of xenon. Anesthesiology 2006; 105: 187-197.
27. Basso DM, Beattie MS, Bresnahan JC,. A sensitive and reliable locomotor rating scale for open field testing in rats. J Neurotrauma 1995; 12: 1-21.
28. Lee JJ, Li L, Jung HH, Zuo Z,. Postconditioning with isoflurane reduced ischemia-induced brain injury in rats. Anesthesiology 2008; 108: 1055-1062.
29. Gruss M, Bushell TJ, Bright DP, Lieb WR, Mathie A, Franks NP,. Two-pore-domain k+ channels are a novel target for the anesthetic gases xenon, nitrous oxide, and cyclopropane. Mol Pharmacol 2004; 65: 443-452.
30. Bantel C, Maze M, Trapp S,. Neuronal preconditioning by inhalational anesthetics: evidence for the role of plasmalemmal adenosine triphosphate-sensitive potassium channels. Anesthesiology 2009; 110: 986-995.
31. Heurteaux C, Guy N, Laigle C, Blondeau N, Duprat F, Mazzuca M, Lang-Lazdunski L, Widmann C, Zanzouri M, Romey G, Lazdunski M,. Trek-1, a k+ channel involved in neuroprotection and general anesthesia. EMBO J 2004; 23: 2684-2695.
32. Dasmahapatra G, Almenara JA, Grant S,. Flavopiridol and histone deacetylase inhibitors promote mitochondrial injury and cell death in human leukemia cells that overexpress bcl-2. Mol Pharmacol 2006; 69: 288-298.
33. Panahian N, Maines MD,. Site of injury-directed induction of heme oxygenase-1 and -2 in experimental spinal cord injury: differential functions in neuronal defense mechanisms? J Neurochem 2001; 76: 539-554.
34. Sakurai M, Hayashi T, Abe K, Sadahiro M, Tabayashi K,. Delayed and selective motor neuron death after transient spinal cord ischemia: a role of apoptosis? J Thorac Cardiovasc Surg 1998; 115: 1310-1315.
35. Karin M, Ben-Neriah Y,. Phosphorylation meets ubiquitination: the control of nf-[kappa]b activity. Annu Rev Immunol 2000; 18: 621-663.
36. Cattano D, Williamson P, Fukui K, Avidan M, Evers AS, Olney JW, Young C,. Potential of xenon to induce or to protect against neuroapoptosis in the developing mouse brain. Can J Anaesth 2008; 55: 429-436.
37. Weber NC, Toma O, Wolter JI, Wirthle NM, Schlack W, Preckel B,. Mechanisms of xenon- and isoflurane-induced preconditioning-a potential link to the cytoskeleton via the mapkapk-2/hsp27 pathway. Br J Pharmacol 2005; 146: 445-455.